SFI
VRCA icon

SPC Financial Inc’s Verrica Pharmaceuticals VRCA Stock Holding History

SPC Financial Inc’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,000
Closed -$15.9K – 289
2025
Q2 		$15.9K Hold
3,000
– – ﹤0.01% 261
2025
Q1 		$13.3K Hold
3,000
– – ﹤0.01% 261
2024
Q4 		$21K Hold
3,000
– – ﹤0.01% 259
2024
Q3 		$43.5K Hold
3,000
– – ﹤0.01% 252
2024
Q2 		$219K Hold
3,000
– – 0.02% 234
2024
Q1 		$178K Hold
3,000
– – 0.02% 226
2023
Q4 		$220K Hold
3,000
– – 0.02% 215
2023
Q3 		$117K Hold
3,000
– – 0.01% 206
2023
Q2 		$173K Buy
+3,000
New +$182K 0.02% 214

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return